Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales

<strong>Background<br></strong> UK COVID-19 vaccination policy has evolved to offering COVID-19 booster doses to individuals at increased risk of severe Illness from COVID-19. Building on our analyses of vaccine effectiveness of first, second and initial booster doses, we aimed to...

Full description

Bibliographic Details
Main Authors:	Bedston, S, Almaghrabi, F, Patterson, L, Agrawal, U, Woolford, L, Anand, SN, Joy, M, Crawford, A, Goudie, R, Byford, R, Abbasizanjani, H, Smith, D, Laidlaw, L, Akbari, A, Sullivan, C, Bradley, DT, Lyons, RA, de Lusignan, S, Hobbs, FDR, Robertson, C, Sheikh, SA, Shi, T
Format:	Journal article
Language:	English
Published:	Elsevier 2023

Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales

Similar Items